Wefel, J. S., Pugh, S., Gondi, V., Brown, P. D., Tome, W., Armstrong, T. S., Bruner, D., Bovi, J., Robinson, C., Khuntia, D., Grosshans, D., Konski, A., Roberge, D., Kundapur, V., Devisetty, K., Shah, S., Usuki, K., Anderson, B., Mehta, M. P., & Kachnic, L. (n.d.). nRG Oncology CC001 Neurocognitive Final Analysis: A Phase III Trial of Hippocampal Avoidance (HA) in Addition to Whole-Brain Radiotherapy (WBRT) Plus Memantine to Preserve Neurocognitive Function (NCF) in Patients With Brain Metastases (BM). Neurosurgery, 66, . http://access.bl.uk/ark:/81055/vdc_100183615533.0x00003d